Advanced Search Results For "Budesonide"
Your filters
[Pharmacoeconomics analysis of using a fixed combination of budesonide/formoterol in patients with asthma in the health care system of the Russian Federation].
Publication Type: Academic Journal
Source(s): Terapevticheskii arkhiv [Ter Arkh] 2022 Aug 12; Vol. 94 (7), pp. 850-858. Date of Electronic Publication: 2022 Aug 12.
Abstract: Aim: To evaluate the budgetary impact of using budesonide + formoterol (Symbicort Turbuhaler) as maintenance therapy in real clinical practice compared with standard therapy for asthma of varying severity: for mild asthma with on-demand salbutamol; for...
Effect of budesonide on pulmonary activity of multidrug resistance-associated protein 1 assessed with PET imaging in rats.
Publication Type: Academic Journal
Source(s): European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences [Eur J Pharm Sci] 2023 May 01; Vol. 184, pp. 106414. Date of Electronic Publication: 2023 Feb 27.
Abstract: Multidrug resistance-associated protein 1 (MRP1/ABCC1) is a highly abundant efflux transporter in the lungs, which protects cells from toxins and oxidative stress and has been implicated in the pathophysiology of chronic obstructive pulmonary disease a...
The Genotoxic Effect of Nasal Steroids on Human Nasal Septal Mucosa and Cartilage Cells In Vitro.
Publication Type: Academic Journal
Source(s): The Annals of otology, rhinology, and laryngology [Ann Otol Rhinol Laryngol] 2023 May; Vol. 132 (5), pp. 497-503. Date of Electronic Publication: 2022 Jun 11.
Abstract: Objective: To determine whether budesonide (Bud) and triamcinolone acetate (TA) cause DNA fractures in the nasal mucosa and septal cartilage cells through examinations using the comet assay technique.Study Design: Prospective, controlled experimental s...
Effects of Combined Use of Salbutamol/Budesonide in Thoracic Surgery on Postoperative Myocardial Injury (MINS) - A Prospective Randomized Clinical Trial.
Publication Type: Report
Source(s): Drug design, development and therapy [Drug Des Devel Ther] 2023 Apr 01; Vol. 17, pp. 1025-1036. Date of Electronic Publication: 2023 Apr 01 (Print Publication: 2023).
Abstract: Purpose: This study aims to investigate whether the administration of salbutamol/budesonide reduced the incidence of myocardial injury in thoracic surgery.Methods: The randomized controlled trial included 298 patients over 45 and at high-risk for cardi...
Safety of an investigational formulation of budesonide (budesonide oral suspension) for eosinophilic oesophagitis: an integrated safety analysis of six phase 1-3 clinical trials.
Publication Type: Academic Journal
Source(s): Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2023 May; Vol. 57 (10), pp. 1117-1130. Date of Electronic Publication: 2023 Mar 08.
Abstract: Background: Questions remain regarding the safety of swallowed topical corticosteroids in eosinophilic oesophagitis (EoE).Aim: To assess the safety of an investigational formulation of budesonide (budesonide oral suspension; BOS) from six trials.Method...
Budesonide as first-line treatment in patients with autoimmune hepatitis seems inferior to standard predniso(lo)ne administration.
Publication Type: Academic Journal
Source(s): Hepatology (Baltimore, Md.) [Hepatology] 2023 Apr 01; Vol. 77 (4), pp. 1095-1105. Date of Electronic Publication: 2023 Jan 03.
Abstract: Background and Aims: In patients with non-severe acute or chronic autoimmune hepatitis (AIH) without cirrhosis, clinical practice guidelines recommend indistinct use of prednisone or budesonide. However, budesonide is infrequently used in clinical prac...
Treatment of autoimmune hepatitis: Budesonide does not solve our problems.
Publication Type: Editorial & Opinion
Source(s): Hepatology (Baltimore, Md.) [Hepatology] 2023 Apr 01; Vol. 77 (4), pp. 1071-1073. Date of Electronic Publication: 2023 Feb 03.
Airborne allergic contact dermatitis "by proxy" due to budesonide.
Publication Type: Academic Journal
Source(s): Italian journal of dermatology and venereology [Ital J Dermatol Venerol] 2023 Apr; Vol. 158 (2), pp. 152-153. Date of Electronic Publication: 2023 Mar 23.
Efficacy and Safety of As-Needed Budesonide-Formoterol in Adolescents with Mild Asthma.
Publication Type: Academic Journal
Source(s): The journal of allergy and clinical immunology. In practice [J Allergy Clin Immunol Pract] 2021 Aug; Vol. 9 (8), pp. 3069-3077.e6. Date of Electronic Publication: 2021 Apr 22.
Abstract: Background: Medication adherence is challenging for adolescents. In mild asthma, as-needed budesonide-formoterol (BUD-FORM) reduces severe exacerbations compared with as-needed short-acting beta 2 -agonists, similar to the reduction with maintenance bu...
Adherence and quality of life assessment in patients with asthma treatment with budesonide/formoterol via the Elpenhaler device: the COMPLETE study.
Publication Type: Academic Journal
Source(s): BMC pulmonary medicine [BMC Pulm Med] 2022 Jun 27; Vol. 22 (1), pp. 254. Date of Electronic Publication: 2022 Jun 27.
Abstract: Background: Asthma is a chronic inflammatory disease of the airways that causes recurring episodes of wheezing, breathlessness, chest tightness and coughing. Inhaled drugs on a daily basis are the cornerstone of asthma treatment, therefore, patient adh...